The thing that hit hardest wasn't a single dramatic symptom — it was the creeping sense that everything hurt slightly more than it used to, and nobody could explain why. Waistbands felt unbearable, loud noises felt assaulting, a firm handshake felt like a squeeze too many. When the words 'central sensitization' finally appeared, it felt less like a diagnosis and more like someone finally turning on a light in a room that had been dark for years.
Learn more about Rose →Estrogen doesn't just regulate the reproductive system — it acts directly on the central nervous system to dampen the transmission of pain signals, particularly in the spinal dorsal horn where incoming pain messages are filtered before reaching conscious awareness. When estrogen levels fall during perimenopause, this inhibitory brake is progressively removed, leaving pain pathways more excitable and reactive than before. This is not a metaphor or a mood effect; it reflects a real change in neurochemistry that has been documented in animal models and supported by human imaging studies.
The body has a built-in pain-dampening highway called the descending inhibitory pathway, which runs from the brain down into the spinal cord and essentially tells the nervous system to 'turn down' incoming pain signals. Estrogen supports the activity of key neurotransmitters in this pathway, including serotonin and norepinephrine, both of which are critical to its function. As estrogen declines, this top-down control weakens, and the nervous system becomes less able to regulate or modulate pain on its own — which is why pain that was once manageable can suddenly feel overwhelming.
Central sensitization involves a process called wind-up, where repeated stimulation of pain receptors causes the spinal cord to respond with increasingly exaggerated signals — essentially turning up the volume on pain over time rather than habituating to it. Estrogen normally helps prevent excessive wind-up by moderating NMDA receptor activity, a key driver of this amplification process. With less estrogen present, NMDA receptors become easier to activate, meaning that minor or repeated irritants — a tight waistband, a repetitive motion, even a massage — can trigger disproportionately intense pain responses.
Joint and muscle pain ranks among the most commonly reported symptoms in perimenopause, yet it frequently goes unconnected to hormonal changes in clinical conversations. Studies including data from the Study of Women's Health Across the Nation (SWAN) have confirmed that musculoskeletal pain increases significantly during the menopausal transition, even after controlling for age and other confounders. Central sensitization helps explain why this pain is often diffuse and hard to localize — it's the sensitivity of the system itself that has changed, not necessarily the condition of any specific joint or muscle.
Fibromyalgia, a condition defined by widespread pain hypersensitivity and considered a prototypical central sensitization disorder, is diagnosed predominantly in women, and incidence rises sharply in the perimenopausal years. Research has identified lower estrogen levels as a contributing factor in fibromyalgia symptom severity, and some studies show that hormonal management can modestly improve pain scores in affected women. This overlap between fibromyalgia and perimenopause strongly suggests that estrogen withdrawal is capable of tipping a predisposed nervous system into a state of chronic central sensitization.
Migraine is itself a form of central sensitization — the trigeminal pain pathways become hyper-reactive during an attack, and in chronic migraine this sensitization can persist between episodes. Estrogen fluctuations are a well-established migraine trigger, and the erratic hormonal swings of perimenopause can make previously manageable migraine patterns escalate dramatically in both frequency and intensity. The sensitized pain system doesn't distinguish between headache pain and other pain; a more reactive nervous system is a more reactive nervous system across the board.
Poor sleep is both a symptom of perimenopause and an independent driver of central sensitization — and the two feed each other in ways that can rapidly escalate pain burden. Even one night of disrupted sleep has been shown in controlled studies to measurably lower pain thresholds the following day, and the chronic sleep disruption common in perimenopause compounds this effect over weeks and months. Estrogen loss contributes to the sleep disruption through night sweats and altered sleep architecture, effectively creating a self-reinforcing loop where hormonal change degrades sleep and degraded sleep amplifies pain.
Women in perimenopause frequently report that sensory experiences they previously tolerated with ease — tight clothing, background noise, bright screens — have become genuinely uncomfortable or even painful. This phenomenon, sometimes called sensory hypersensitivity or allodynia when touch is involved, is a direct expression of a centrally sensitized nervous system that has lost its normal filtering capacity. Because estrogen receptors are present throughout the brain including in regions that process non-pain sensory input, its withdrawal can lower thresholds for multiple sensory modalities simultaneously, not just traditional pain.
One of the strongest pieces of indirect evidence that estrogen withdrawal drives central sensitization is the observation that hormone therapy (HT) can reduce widespread pain, migraine frequency, and tactile sensitivity in perimenopausal women. Clinical trials examining HT in fibromyalgia and chronic widespread pain have shown modest but meaningful improvements in pain measures, and population studies suggest that women using HT report less musculoskeletal pain overall. If the pain were purely structural or purely psychological, restoring estrogen would not have this effect — but it does, which points directly back to the central, neurochemical mechanism.
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.